ストックスクリーナーアプリを入手
70.80
1.67%
-1.1827
前日終値:
$71.98
開ける：
$70.1
24時間の取引高:
6.49M
Relative Volume:
1.01
時価総額：
$12.84B
収益：
$1.36B
当期純損益:
$-302.91M
株価収益率:
-41.20
EPS:
-1.7182
ネットキャッシュフロー:
$-219.93M
1週間 パフォーマンス:
-13.58%
1か月 パフォーマンス:
+9.52%
6か月 パフォーマンス:
+51.18%
1年 パフォーマンス:
-23.91%
1日の値動き範囲:
$68.66
$73.09
1週間の範囲:
$68.66
$87.99
52週間の値動き範囲:
$40.77
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Compare TEM vs VEEV, BTSG, TXG, HNGE
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
70.71 | 15.43B | 1.36B | -302.91M | -219.93M | -1.7182 |
VEEV
Veeva Systems Inc
|
284.88 | 45.44B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
64.29 | 11.20B | 13.65B | 169.86M | 412.12M | 1.0758 |
TXG
10 X Genomics Inc
|
77.30 | 11.17B | 638.78M | -22.66M | 122.18M | -0.1744 |
HNGE
Hinge Health Inc
|
98.70 | 7.71B | 646.34M | -512.40M | 202.76M | -6.6871 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-13 | 開始されました | Jefferies | Underperform |
| 2026-04-13 | アップグレード | TD Cowen | Hold → Buy |
| 2026-02-19 | 開始されました | Mizuho | Outperform |
| 2026-02-17 | 開始されました | Robert W. Baird | Outperform |
| 2025-12-02 | 再開されました | Morgan Stanley | Overweight |
| 2025-10-21 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-10-20 | 開始されました | Canaccord Genuity | Buy |
| 2025-09-02 | 開始されました | H.C. Wainwright | Buy |
| 2025-04-21 | 開始されました | BTIG Research | Buy |
| 2025-02-25 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2025-02-12 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | 再開されました | TD Cowen | Buy |
| 2024-12-13 | 開始されました | Wolfe Research | Outperform |
| 2024-12-09 | 開始されました | Guggenheim | Buy |
| 2024-11-11 | ダウングレード | Stifel | Buy → Hold |
| 2024-10-02 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-08-12 | 開始されました | Piper Sandler | Neutral |
| 2024-07-09 | 開始されました | BofA Securities | Buy |
| 2024-07-09 | 開始されました | JP Morgan | Overweight |
| 2024-07-09 | 開始されました | Longbow | Buy |
| 2024-07-09 | 開始されました | Loop Capital | Buy |
| 2024-07-09 | 開始されました | Morgan Stanley | Overweight |
| 2024-07-09 | 開始されました | Needham | Buy |
| 2024-07-09 | 開始されました | Stifel | Buy |
| 2024-07-09 | 開始されました | TD Cowen | Buy |
| 2024-07-09 | 開始されました | William Blair | Outperform |
すべてを表示
Tempus Ai Inc (TEM) 最新ニュース
Tempus AI (NASDAQ:TEM) Shares Down 6.1%Here's Why - MarketBeat
Tempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026 - Business Wire
What Does Today’s Signal Mean for Tempus AI (NASDAQ:TEM)? - Kalkine Media
$Tempus AI (TEM.US)$ - Moomoo
A trading plan governed the sale of 10,281 Tempus AI (TEM) shares by its diagnostics CEO at $85 each. - Stock Titan
Tempus AI, Inc. Class A Bonds — Corporate Bond Rates - TradingView
Why Tempus AI (TEM) Stock Is Down Today - Quiver Quantitative
Best Artificial Intelligence Stocks To ConsiderSeptember 29th - MarketBeat
Current ratio of Tempus AI, Inc. Class A – HAN:F3M - TradingView
Tempus AI Has Three FDA-Cleared ECG Algorithms - FourWeekMBA
Tempus AI receives FDA clearance for heart valve AI tool - Investing.com
Tempus AI receives FDA clearance for heart valve AI tool By Investing.com - Investing.com India
Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral Regurgitation - Business Wire
Cathie Wood's Ark Invest weekly recap: boosts Meta, Rocket Lab; cuts Tempus AI, CrowdStrike (ARKK:BATS) - Seeking Alpha
Tempus AI CEO Ryan Fukushima sells $49,000 in stock By Investing.com - Investing.com South Africa
Tempus AI CEO Lefkofsky sells $16.1m common stock By Investing.com - Investing.com South Africa
Tempus AI CEO Lefkofsky sells $16.1m common stock - Investing.com
Tempus AI CEO Ryan Fukushima sells $49,000 in stock - Investing.com
Tempus AI CAO Ryan Bartolucci sells $529,650 in stock - Investing.com
Form 4 Tempus AI Inc For: 27 September By Investing.com - Investing.com Canada
Tempus AI EVP Andrew Polovin sells 2,951 shares for $221,325 - Investing.com
Form 144 Tempus AI For: 27 September - Investing.com India
Artificial Intelligence Stocks To Watch TodaySeptember 26th - MarketBeat
Tempus AI gets FDA clearance for pulmonary hypertension AI tool - scanx.trade
Tempus AI, Inc. Class A Ignites Investor Hype - TipRanks
Form 144 Tempus AI For: 26 September - Investing.com India
Form 144 Tempus AI For: 26 September By Investing.com - Investing.com Australia
Artificial Intelligence Stocks To Follow TodaySeptember 25th - MarketBeat
Tempus AI, Inc. (TEM) options chain - Yahoo Finance Australia
Tempus AI, Inc. (TEM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Leica Biosystems brings Tempus pathology products to Aperio AI Store, accelerating AI-powered capabilities for oncology research - News-Medical
AI in Clinical Trials Market Set for Transformative Growth Through 2040, Unlocking Opportunities Across Trial Phases, Therapeutic Areas, End Users and Key Global Regions - GlobeNewswire Inc.
#Day 10Looking to Take Profit on my tempus - Moomoo
Tempus AI (NASDAQ:TEM) CEO Sells 250,000 Shares of Company Stock - MarketBeat
RXRX Stock Rises As Tempus AI Deal Resets Growth Story - StocksToTrade
Tempus AI(TEM.US) 10% Shareholder Sells US$19.37 Million in Common Stock - moomoo.com
Tempus AI CEO-linked entities sell 250,000 shares - Stock Titan
Tempus AI Inc Stock (TEM) Closed Up by 7.38% on Sep 24: What Investors Need To Know - TradingKey
Tempus AI (NASDAQ:TEM) Trading 6.1% HigherTime to Buy? - MarketBeat
Tempus AI Soars As Wall Street Bets On Data - TipRanks
Promising Artificial Intelligence Stocks To ConsiderSeptember 24th - MarketBeat
Tempus AI Chief Accounting Officer Sells $529,650 of Stock - The Globe and Mail
Buy 3 AI-Powered Medical Stocks to Strengthen Your Portfolio in Q4 - finance.yahoo.com
Cathie Wood’s ARK sells Tempus AI stock, buys Scribe Therapeutics By Investing.com - Investing.com South Africa
Cathie Wood’s ARK sells Tempus AI stock, buys Scribe Therapeutics - Investing.com
Tempus AI (TEM) Has a $75 Goldman Sachs Target, But Its Data Business Faces a Bigger Test - Yahoo Finance
Tempus AI Stock Price: TEM Stock Chart, Market Cap & News Today - CoinGecko
Tempus AI (NASDAQ:TEM) Upgraded by The Goldman Sachs Group to Hold Rating - MarketBeat
Tempus AI: High Risk, But With A Great Cause (NASDAQ:TEM) - Seeking Alpha
Goldman Sachs initiates coverage of Tempus AI (TEM.US) with a Neutral rating: Diagnostic business to benefit from reimbursement tailwinds, while data contracts enter a "validation phase" - moomoo.com
Tempus AI: Data And Applications Will Unlock More Upside (NASDAQ:TEM) - Seeking Alpha
Tempus Ai Inc (TEM) 財務データ
収益
当期純利益
現金流量
EPS
0.85%
3.94%
大文字化:
|
ボリューム (24 時間):